These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2877550)

  • 1. B lymphocyte population and immunoglobulins in Indian kala-azar in response to chemotherapy.
    Neogy AB; Nandy A; Dastidar BG; Chowdhury AB
    Acta Trop; 1986 Sep; 43(3):237-44. PubMed ID: 2877550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological investigations on Indian kala-azar.
    Ghose AC; Haldar JP; Pal SC; Mishra BP; Mishra KK
    Clin Exp Immunol; 1980 May; 40(2):318-26. PubMed ID: 7438541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological findings in kala-azar, Iran.
    Behforouz NC; Amirhakimi GH; Rezai HR; Saberi MS
    Trop Geogr Med; 1983 Mar; 35(1):27-32. PubMed ID: 6612770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged sodium stibogluconate therapy in Indian kala-azar.
    Jha TK; Sharma VK
    J Assoc Physicians India; 1986 Jul; 34(7):469-71. PubMed ID: 3019993
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy.
    Anam K; Afrin F; Banerjee D; Pramanik N; Guha SK; Goswami RP; Saha SK; Ali N
    Infect Immun; 1999 Dec; 67(12):6663-9. PubMed ID: 10569788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the cell-mediated immune response in kala-azar and post-kala-azar dermal leishmaniasis in relation to chemotherapy.
    Neogy AB; Nandy A; Ghosh Dastidar B; Chowdhury AB
    Ann Trop Med Parasitol; 1988 Feb; 82(1):27-34. PubMed ID: 2840867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of interferon-gamma, interleukin-10, and interleukin-6 during active disease in Indian kala azar.
    Ansari NA; Saluja S; Salotra P
    Clin Immunol; 2006 Jun; 119(3):339-45. PubMed ID: 16540374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Qualitative and quantitative behavior of B-lymphocytes and immunoglobulins in the serum of children with acute leukemia after a single immunoglobulin concentrate substitution].
    Radke M; Schulz N; Blau HJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):392-9. PubMed ID: 6169600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kala-azar: unresponsiveness to prolonged sodium stibogluconate therapy.
    Bhattacharya D; Majhi TK; Dutta RK
    J Assoc Physicians India; 1987 Jul; 35(7):543. PubMed ID: 2828305
    [No Abstract]   [Full Text] [Related]  

  • 10. [T and B lymphocytes before, during, and after cytostatic therapy of acute lymphoblastic leukemia (ALL) in children (author's transl)].
    Wehinger H; Karitzky D
    Klin Padiatr; 1977 May; 189(3):234-41. PubMed ID: 301585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of kala azar and its treatment in Kenya.
    Chunge CN; Gachihi G; Chulay JD; Spencer HC
    East Afr Med J; 1984 Feb; 61(2):120-7. PubMed ID: 6088210
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
    Hann HW; Deacon JC; London WT
    Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some factors of immunopathogenesis of infectious mononucleosis in children.
    Rudkowski Z; Kacprzak-Bergman I; Jankowski A; Krawczyk K
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):101-4. PubMed ID: 6293402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunodiagnostic findings in patients with kala-azar].
    Mannweiler E; Lederer I; Feldmeier H
    Dtsch Med Wochenschr; 1988 Sep; 113(37):1428-32. PubMed ID: 3046895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium antimony resistant cases of kala-azar in and around Patna (south Bihar).
    Sehgal PN; Murmu C; Chatteyee AK
    J Commun Dis; 1988 Jun; 20(2):161-2. PubMed ID: 2853714
    [No Abstract]   [Full Text] [Related]  

  • 16. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.
    Cambridge G; Leandro MJ; Edwards JC; Ehrenstein MR; Salden M; Bodman-Smith M; Webster AD
    Arthritis Rheum; 2003 Aug; 48(8):2146-54. PubMed ID: 12905467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematological and serological aspects of Mediterranean kala-azar in infancy and childhood.
    Li Volti S; Fischer A; Musumeci S
    Acta Trop; 1980 Dec; 37(4):351-65. PubMed ID: 6110325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.
    Karki P; Koirala S; Parija SC; Hansdak SG; Das ML
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):154-8. PubMed ID: 9740292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECG changes in prolonged treatment of kala-azar with antimony compounds.
    Pandey AK; Kumar M; Thakur CP
    J Assoc Physicians India; 1988 Jun; 36(6):398-9. PubMed ID: 2846508
    [No Abstract]   [Full Text] [Related]  

  • 20. [Development of serum immunoglobulins (IgG, IgA, IgM): studies of the child population of Puglia].
    De Mattia D; Altomare M; Montagna O
    Boll Soc Ital Biol Sper; 1977 Jun; 53(12):977-82. PubMed ID: 597430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.